Biomimetic Self-Oxygenated Immunoliposome for Cancer-Targeted Photodynamic Immunotherapy
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s508696 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Yucheng Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China. Hauptthemen laut MEDLINE: Photochemotherapy, Liposomes, Immunotherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, People's Republic of China.
- Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, 410011, People's Republic of China.
- Institute of Clinical Pharmacy, Central South University, Changsha, 410011, People's Republic of China.
ORCID-Profile: Yongjiang Li, Xiongbin Hu
Zitieren
APA
Tang, Y., Tang, T., Li, Y., Wu, J., Liu, X., Xiang, D., & Hu, X. (2025). Biomimetic Self-Oxygenated Immunoliposome for Cancer-Targeted Photodynamic Immunotherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s508696
Vancouver
Tang Y, Tang T, Li Y, Wu J, Liu X, Xiang D, et al. Biomimetic Self-Oxygenated Immunoliposome for Cancer-Targeted Photodynamic Immunotherapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s508696
BibTeX
@article{Tang2025,
author = {Tang, Yucheng and Tang, Tiantian and Li, Yongjiang and Wu, Junyong and Liu, Xinyi and Xiang, Daxiong and Hu, Xiongbin},
title = {Biomimetic Self-Oxygenated Immunoliposome for Cancer-Targeted Photodynamic Immunotherapy},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s508696}
}
EUVIMED